Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 470 pseudogene (abbreviated as ZNF470P, also called LOC100421074) is a human pseudogene annotated in genomic databases such as Ensembl with the ID ENSG00000248106. Pseudogenes such as this are non-coding segments of DNA that resemble genes but do not produce functional proteins, typically due to disabling mutations or lack of regulatory elements. While functional members of the zinc finger protein family are known to act as DNA-binding transcription factors and play diverse roles in gene expression regulation and genome stability[1][3][5][6], the ZNF470 pseudogene does not encode an active protein and its biological function, if any, is unknown. There is no evidence it serves as a therapeutic target, biomarker, or drug-interaction partner, nor is it recognized as having clinical or pharmacological roles. Its classification as a pseudogene explains missing data for function, disease association, or molecular action[5][6]. Additional context and notes: - The canonical name and abbreviation are derived from standard gene nomenclature databases and match scientific convention for human pseudogenes. - The 'is_incorrect' field is true because this entry refers to a pseudogene and not to a functional molecule or receptor; it is not a therapeutic target, and most structured biomedical resources do not treat non-coding pseudogenes as drug targets or clinically relevant entities. - Aliases are gathered from multiple nomenclature sources, but there are no well-established protein products or synonyms beyond database identifiers. - Molecular classification reflects its structural annotation as a pseudogene within the zinc finger family, a large group that includes both functional genes and pseudogenes[1][3][5][6]. - No data are available for the structured fields relating to biological activity, disease role, drug action, biomarkers, or safety profile, consistent with current knowledge and omission from therapeutic target lists.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 470 pseudogene (ZNF470P).